A phase 1 study of the sachet formulation of the oral dual PI3K/mTOR inhibitor BEZ235 given twice daily (BID) in patients with advanced solid tumors (Q33420634)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase 1 study of the sachet formulation of the oral dual PI3K/mTOR inhibitor BEZ235 given twice daily (BID) in patients with advanced solid tumors |
scientific article |
Statements
1 reference
A phase 1 study of the sachet formulation of the oral dual PI3K/mTOR inhibitor BEZ235 given twice daily (BID) in patients with advanced solid tumors (English)
1 reference
Johanna C Bendell
1 reference
Carla Kurkjian
1 reference
Jeffrey R Infante
1 reference
Todd M Bauer
1 reference
Howard A Burris
1 reference
F Anthony Greco
1 reference
Kent C Shih
1 reference
Dana S Thompson
1 reference
Cassie M Lane
1 reference
Lindsey H Finney
1 reference
Suzanne F Jones
1 reference
25 February 2015
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference